STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 60 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,159,000 | -6.7% | 4,489,687 | +35.8% | 4.17% | -18.8% |
| Q2 2021 | $9,818,000 | +698.2% | 3,305,617 | +641.7% | 5.13% | +673.2% |
| Q1 2021 | $1,230,000 | -62.5% | 445,701 | -67.0% | 0.66% | -73.6% |
| Q4 2020 | $3,281,000 | -18.8% | 1,350,000 | -29.9% | 2.51% | -40.3% |
| Q3 2020 | $4,042,000 | +347.6% | 1,924,956 | +345.7% | 4.20% | +568.5% |
| Q4 2019 | $903,000 | +77.8% | 431,853 | +166.2% | 0.63% | +79.7% |
| Q2 2019 | $508,000 | -45.5% | 162,244 | -13.3% | 0.35% | -34.7% |
| Q1 2019 | $932,000 | -62.7% | 187,074 | -45.7% | 0.54% | -64.2% |
| Q4 2017 | $2,496,000 | – | 344,282 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $15,803,000 | 17.82% |
| Prosight Management, LP | 2,515,072 | $6,011,000 | 3.33% |
| 22NW, LP | 804,410 | $1,923,000 | 2.54% |
| Broadfin Capital, LLC | 2,578,003 | $6,161,000 | 1.14% |
| NEA Management Company, LLC | 4,141,308 | $9,898,000 | 0.82% |
| Opaleye Management Inc. | 490,000 | $1,171,000 | 0.42% |
| PA Capital LLC | 152,977 | $366,000 | 0.36% |
| 683 Capital Management, LLC | 923,700 | $2,208,000 | 0.25% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 414,982 | $992,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,475,000 | $3,525,000 | 0.10% |